BioCryst Pharmaceuticals Inc. (BCRX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioCryst Pharmaceuticals ...

    NASDAQ: BCRX · Real-Time Price · USD
    7.15
    -0.18 (-2.46%)
    At close: Oct 03, 2025, 3:59 PM
    7.24
    1.26%
    After-hours: Oct 03, 2025, 07:55 PM EDT

    BioCryst Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -88.88M -226.54M -247.12M -184.06M
    Depreciation & Amortization
    		 1.25M 1.66M 1.44M 777K
    Stock-Based Compensation
    		 65.41M 55.62M 44.7M 34.64M
    Other Working Capital
    		 1.96M -8.05M -2.69M 1.28M
    Other Non-Cash Items
    		 57.48M 106.53M 98.07M -1.64M
    Deferred Income Tax
    		 n/a n/a n/a -55.84M
    Change in Working Capital
    		 -87.28M -32.4M -58.95M 8.12M
    Operating Cash Flow
    		 -52.02M -95.14M -161.85M -142.16M
    Capital Expenditures
    		 -1.12M -2.17M -1.35M -2.38M
    Cash Acquisitions
    		 n/a n/a 1.35M 2.38M
    Purchase of Investments
    		 -266.76M -514.41M -244.28M -10.01M
    Sales Maturities Of Investments
    		 320.48M 385.08M 117.4M 28.2M
    Other Investing Acitivies
    		 n/a n/a -1.35M n/a
    Investing Cash Flow
    		 52.59M -131.5M -128.24M 15.8M
    Debt Repayment
    		 -1.7M 58.38M 73.07M 293.87M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -4.09M -25.9M 14.77M 15.73M
    Financial Cash Flow
    		 -5.76M 32.48M 88.03M 359.67M
    Net Cash Flow
    		 -6.12M -193.79M -201.5M 233.39M
    Free Cash Flow
    		 -53.14M -97.31M -163.2M -144.54M

    Add to Watchlist